Dublin, Aug. 15, 2018 (GLOBE NEWSWIRE) -- The "Hydroxyapatite Market by Type (Nano-sized, Micro-sized, Greater than Micrometers), Application (Orthopedic, Dental Care, Plastic Surgery), and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The HAp market is projected to grow from USD 2.22 billion in 2018 to USD 2.97 billion by 2023, at a CAGR of 5.9% between 2018 and 2023.
Growing geriatric population, increasing healthcare expenditure, and increasing demand for medical implants are some of the drivers fueling the growth of the HAp market across the globe. However, some of the major restraints for the growth of the HAp market are unfavorable healthcare reforms in the US and unmet performance benchmark by hydroxyapatite such as it has low fracture toughness.
The micro-sized hydroxyapatite is used in various applications. Along with orthopedic and dental care applications, micro-sized hydroxyapatite is also used in maxillofacial surgeries, oculo-orbital surgeries, and dermal fillers and implants. The micro-sized hydroxyapatite is used in the pharmaceutical applications for controlled delivery of genes and proteins to the target tissues.
The nano-engineered micro-sized hydroxyapatite is expected to widen the application window and improve the performance of hydroxyapatite. The improving performance and widening application scope of micro-sized hydroxyapatite are estimated to fuel the growth of the micro-sized segment of the HAp market during the forecast period.
Hydroxyapatite is majorly used in enamel and dental care solutions in the oral care industry. It is one of the main components of teeth that accounts for 97% of enamel and 70% of dentin. In the dental care application, hydroxyapatite is widely preferred over fluoride for remineralization of teeth surfaces. Hydroxyapatite granules are used in various clinical dental practices such as the reconstruction of periodontal bone defects; filling bone defects after cystectomy, after apicoectomy, and after the loss of dental implants; and increasing the thickness of atrophic alveolar ridges.
The Asia Pacific HAp market is projected to grow at the highest CAGR during the forecast period. The growth of the Asia Pacific HAp market can be attributed to the flourishing healthcare sector in the region. The orthopedic application segment led the Asia Pacific HAp market in 2017, followed by the dental care application segment. Countries such as China, Japan, India, and South Korea are experiencing rapid growth in the medical tourism, thereby leading to the growth of their domestic healthcare sectors.
This, in turn, is expected to fuel the growth of the HAp market in the region. Moreover, the increasing awareness among masses about the cost-effective treatments and rapidly developing infrastructure of the medical sector in these countries are expected to lead to the growth of the Asia Pacific HAp market during the forecast period.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Attractive Growth Opportunity for HAp Market
4.2 APAC HAp Market, By Application
4.3 HAp Market, By Application
4.4 HAp Market, By Region
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Continuous R&D Activities to Increase the Applicability of HAp in the Medical Industry
5.2.1.2 Growing Demand for Implants
5.2.2 Restraints
5.2.2.1 Unfavorable Healthcare Reforms in the US
5.2.3 Opportunities
5.2.3.1 Growing Healthcare Industry and Easy Availability of Raw Materials in APAC
5.2.4 Challenges
5.2.4.1 Unmet Performance Benchmark and Increasing Popularity of Bioresorbable Composites
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Buyers
5.3.2 Bargaining Power of Suppliers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Intensity of Competitive Rivalry
6 Hydroxyapatite Market, By Type
6.1 Introduction
6.2 Nano-Sized
6.3 Micro-Sized
6.4 Greater Than Micrometer
7 Hydroxyapatite Market, By Application
7.1 Introduction
7.2 Orthopedic
7.3 Dental Care
7.4 Plastic Surgery
7.5 Others
8 HAp Market, By Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Rest of North America
8.3 Europe
8.3.1 France
8.3.2 Russia
8.3.3 Germany
8.3.4 UK
8.3.5 Portugal
8.3.6 Rest of Europe
8.4 APAC
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Rest of APAC
8.5 Rest of the World
9 Company Profiles
9.1 Fluidinova
9.2 Sofsera
9.3 Berkeley Advanced Biomaterials
9.4 Taihei Chemical Industrial Co. Ltd.
9.5 Sigmagraft
9.6 Cam Bioceramics
9.7 Zimmer Biomet
9.8 APS Materials
9.9 CG Bio Inc.
9.10 Granulab (M) Sdn Bhd
For more information about this report visit https://www.researchandmarkets.com/research/bcg3xs/global?w=12
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.